Remarkable response of BRAF(V600E)-mutated metastatic pancreatic cancer to BRAF/MEK inhibition: a case report

por Li, Hong-Shuai, Yang, Ke, Wang, Yan
Publicado 2021

RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS‐mutated lung adenocarcinoma

por Li, Hong‐Shuai, Liu, Cheng‐Ming, Wang, Yan
Publicado 2023

Case Report: Dacomitinib May Not Benefit Patients Who Develop Rare Compound Mutations After Later-Line Osimertinib Treatment

por Li, Hong-Shuai, Yang, Guang-Jian, Wang, Yan
Publicado 2021

Increased proportion of the squamous cell carcinoma component is associated with worse survival in resected gastric adenosquamous carcinoma: A STROBE compliant cohort study

por Li, Hong-Shuai, Chen, Ye, Zhang, Ming-Yi, Cheng, Ke, Zhou, Yu-Wen, Liu, Ji-Yan
Publicado 2020

Remarkable Response of EGFR- and HER2-Amplified Metastatic Colon Cancer to Pyrotinib After Failed Multiline Treatments: A Case Report and Literature Review

por Li, Hong-Shuai, Yang, Li-Li, Zhang, Ming-Yi, Cheng, Ke, Chen, Ye, Liu, Ji-Yan
Publicado 2020

A real‐world study of dacomitinib in later‐line settings for advanced non‐small cell lung cancer patients harboring EGFR mutations

por Li, Hong‐Shuai, Zhang, Jin‐Yao, Yan, Xiang, Xu, Hai‐Yan, Hao, Xue‐Zhi, Xing, Pu‐Yuan, Wang, Yan
Publicado 2022

Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review

por Li, Hong-Shuai, Lei, Si-Yu, Li, Jun-Ling, Xing, Pu-Yuan, Hao, Xue-Zhi, Xu, Fei, Xu, Hai-Yan, Wang, Yan
Publicado 2022

Efficacy of dacomitinib in patients with non-small cell lung cancer carrying complex EGFR mutations: a real-world study

por Li, Hong-Shuai, Li, Jun-Ling, Yan, Xiang, Xu, Hai-Yan, Zhou, Li-Qiang, Hu, Xing-Sheng, Wang, Yu-Ying, Lei, Si-Yu, Wang, Yan
Publicado 2022

Influence of PD‐L1 expression on the efficacy of EGFR‐TKIs in EGFR ‐mutant non‐small cell lung cancer

por Lei, Si‐Yu, Xu, Hai‐Yan, Li, Hong‐Shuai, Yang, Ya‐Ning, Xu, Fei, Li, Jun‐Ling, Wang, Zhi‐Jie, Xing, Pu‐Yuan, Hao, Xue‐Zhi, Wang, Yan
Publicado 2023

Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China

por Li, Hong-Shuai, Yang, Guang-Jian, Cai, Yi, Li, Jun-Ling, Xu, Hai-Yan, Zhang, Tao, Zhou, Li-Qiang, Wang, Yu-Ying, Wang, Jin-Liang, Hu, Xing-Sheng, Yan, Xiang, Wang, Yan
Publicado 2022

Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon EGFR Mutations: A Comparati...

por Li, Hong-Shuai, Wang, Shou-Zheng, Xu, Hai-Yan, Yan, Xiang, Zhang, Jin-Yao, Lei, Si-Yu, Li, Teng, Hao, Xue-Zhi, Zhang, Tao, Yang, Guang-Jian, Zhou, Li-Qiang, Liu, Peng, Wang, Yu-Ying, Hu, Xing-Sheng, Xing, Pu-Yuan, Wang, Yan
Publicado 2022